It is a pharma foreign private limited company based in Bangalore North, Karnataka, India, established in 2022.
2022 | Bangalore North, Karnataka, India | Under LiquidationPraesidia Biotherapeutics Private Limited, a under liquidation foreign private limited company, was established on 14 January 2022 in Bangalore North, Karnataka, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U73100KA2022FTC156670. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.27 M.
It upholds a compliant status. Employing 7 professional, Its leadership includes Sohang Chatterjee (Director), Karthika Nair (Whole-Time Director), Ashish Koppa (Additional Director). Its latest AGM occurred on 23 July 2025, with the balance sheet filed on 31 March 2025. It is based at B-1903, Karle Zenith Residences, 100Ft Kempapura Main Road, Hebbal, Bangalore North, Karnataka, 560045.
U73100KA2022FTC156670
156670
14 January 2022
₹1.00 M
₹0.27 M
Roc Bangalore
Unlisted
Under Liquidation
Explore comprehensive insights into Praesidia Biotherapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sohang Chatterjee | Director | 14 Jan 2022 | Current |
| Karthika Nair | Whole-Time Director | 14 Jan 2022 | Current |
| Ashish Koppa | Additional Director | 27 Sep 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Praesidia Biotherapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Praesidia Biotherapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Praesidia Biotherapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Praesidia Biotherapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Praesidia Biotherapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ashish Koppa was appointed as a Additional Director was appointed as a Additional Director on 27 Sep 2025 & has been associated with this company since 2 months 8 days . was recorded as a recent event.
The activity Praesidia Biotherapeutics Private Limited last Annual general meeting of members was held on 23 Jul 2025 as per latest MCA records. was completed.
Praesidia Biotherapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.
Progress on Sohang Chatterjee was appointed as a Director was appointed as a Director on 14 Jan 2022 & has been associated with this company since 3 years 10 months . was documented.
The activity Karthika Nair was appointed as a Whole-time director was appointed as a Whole-time director on 14 Jan 2022 & has been associated with this company since 3 years 10 months . was completed.
Praesidia Biotherapeutics Private Limited was registered on 14 Jan 2022 with Roc Bangalore & aged 3 years 10 months as per MCA records. was recorded as a recent event.
The CIN of Praesidia Biotherapeutics Private Limited is U73100KA2022FTC156670.
Praesidia Biotherapeutics Private Limited is headquartered at B-1903, Karle Zenith Residences, 100Ft Kempapura Main Road, Hebbal, Bangalore North, Karnataka, 560045.
Praesidia Biotherapeutics Private Limited was incorporated on 14 January 2022.
The current directors of Praesidia Biotherapeutics Private Limited are
The primary industry of Praesidia Biotherapeutics Private Limited is Pharma.
Praesidia Biotherapeutics Private Limited is unlisted.
The authorized capital of Praesidia Biotherapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹0.27 M.
The compliance status of Praesidia Biotherapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX